Literature DB >> 12135544

The traumatic spondylolisthesis of the axis. A biomechanical in vitro evaluation of an instability model and clinical relevant constructs for stabilization.

Markus Arand1, Sylvia Neller, Lothar Kinzl, Lutz Claes, Hans Joachim Wilke.   

Abstract

OBJECTIVE: Stepwise destabilization of the traumatic spondylolisthesis C2 with an increasing anterior defect of C2-C3 was investigated. The three-dimensional stabilizing capabilities of posterior transpedicle screw osteosynthesis and two anterior plate systems C2-C3, the H-plate and the titanium locking plate were tested.
DESIGN: A biomechanical in vitro study was performed using a standardized experimental protocol in a spine tester.
BACKGROUND: The extent of the instability of the traumatic spondylolisthesis of C2 within its different types remains unclear. Posterior and anterior approaches for stabilization exist for patients with isthmusfractures at C2, the stabilizing effect has not been demonstrated yet.
METHODS: The motion levels from C2-C3 in six human specimen were tested in flexion, extension, right and left lateral bending and left and right axial rotation. The specimens were tested intact, after destabilization and after stabilization.
RESULTS: In extension and axial rotation, each step of destabilization decreased the moment significantly, to achieve the range of motion of the intact specimen. In flexion a statistical significant destabilization after separation of the posterior longitudinal ligament was present. The flexibility tests showed an increasing range of motion of the posterior transpedicle screws, with increasing anterior instability markedly in flexion and extension. After H-plate and locking plate fixation, a significant decrease of the range of motion resulted in flexion. The stiffness in flexion and extension increased consecutively, while in lateral bending and axial rotation the transpedicle screw fixation showed the highest stiffness. CONCLUSIONS/RELEVANCE: The traumatic spondylolisthesis of C2 is a significantly unstable injury in case of additional segmental damage of C2-C3. Anterior stabilization in these injuries is mandatory.

Entities:  

Mesh:

Year:  2002        PMID: 12135544     DOI: 10.1016/s0268-0033(02)00037-2

Source DB:  PubMed          Journal:  Clin Biomech (Bristol, Avon)        ISSN: 0268-0033            Impact factor:   2.063


  7 in total

1.  Management of hangman's fracture with percutaneous transpedicular screw fixation.

Authors:  Yao-Sen Wu; Yan Lin; Xiao-Lei Zhang; Nai-Feng Tian; Liao-Jun Sun; Hua-Zi Xu; Yong-Long Chi; Zhi-Jun Pan
Journal:  Eur Spine J       Date:  2012-11-19       Impact factor: 3.134

2.  Posterior C2-C3 Fixation for Unstable Hangman's Fracture.

Authors:  Dong Hwan Jeong; Nam Kyu You; Chul Kyu Lee; Ki Hong Cho; Sang Hyun Kim
Journal:  Korean J Spine       Date:  2013-09-30

3.  Clinical Outcomes of Posterior C2-C3 Fixation for Unstable Hangman's Fracture Compared with Posterior C1-C3 Fusion.

Authors:  Jun Hee Park; Sang Hyun Kim; Ki Hong Cho
Journal:  Korean J Spine       Date:  2014-06-30

4.  Burst C2 Fractures Combined with Traumatic Spondylolisthesis: Can Atlantoaxial Motion Be Preserved? Including Some Technical Tips for Reduction and Fixation.

Authors:  Yasser Assaghir
Journal:  Global Spine J       Date:  2015-12-02

5.  Treatment of Axis Ring Fractures: Recommendations of the Spine Section of the German Society for Orthopaedics and Trauma (DGOU).

Authors:  Matti Scholz; Frank Kandziora; Philipp Kobbe; S Matschke; Philipp Schleicher; Christoph Josten
Journal:  Global Spine J       Date:  2018-09-07

6.  Saradhi's single stage, anterior sequential reduction utilizing C3 for type III hangman's fracture: A novel technique.

Authors:  Vijaya Saradhi Mudumba; S Pavan; Rajesh Alugolu
Journal:  J Craniovertebr Junction Spine       Date:  2022-03-09

7.  Outcomes of surgery for unstable odontoid fractures combined with instability of adjacent segments.

Authors:  Lei Wang; Chao Liu; Qing-Hua Zhao; Ji-Wei Tian
Journal:  J Orthop Surg Res       Date:  2014-08-28       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.